Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Eli Lilly
LLY
|
+$534M |
| 2 |
Amazon
AMZN
|
+$432M |
| 3 |
Abbott
ABT
|
+$420M |
| 4 |
Adobe
ADBE
|
+$365M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$277M |
Top Sells
| 1 |
Sherwin-Williams
SHW
|
+$472M |
| 2 |
Bank of America
BAC
|
+$426M |
| 3 |
TE Connectivity
TEL
|
+$399M |
| 4 |
Atlassian
TEAM
|
+$364M |
| 5 |
Goldman Sachs
GS
|
+$348M |
Sector Composition
| 1 | Technology | 32.59% |
| 2 | Healthcare | 19.51% |
| 3 | Consumer Discretionary | 9.8% |
| 4 | Financials | 9.76% |
| 5 | Industrials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Prothena Corp
PRTA
$457M
| $74M | 0.04% |
2,035,984
+209,375
| +11% | +$7.61M |
|
302
Hartford Financial Services
HIG
$36.7B
| $73.4M | 0.04% |
913,556
-7,508
| -0.8% | -$603K |
|
303
HealthEquity
HQY
$8.02B
| $72.2M | 0.04% |
1,088,267
+899
| +0.1% | +$59.6K |
|
304
Sabra Healthcare REIT
SBRA
$4.6B
| $72.1M | 0.04% |
5,054,134
+760,657
| +18% | +$10.9M |
|
305
Neogen
NEOG
$1.23B
| $72M | 0.04% |
3,581,946
+257,670
| +8% | +$5.18M |
|
306
PTC Therapeutics
PTCT
$4.52B
| $72M | 0.04% |
2,612,593
-459,727
| -15% | -$12.7M |
|
307
Brown-Forman Class B
BF.B
$13B
| $71.7M | 0.04% |
1,256,177
+315,245
| +34% | +$18M |
|
308
Innospec
IOSP
$2.12B
| $71.6M | 0.04% |
581,053
+916
| +0.2% | +$113K |
|
309
DexCom
DXCM
$30.6B
| $71.3M | 0.04% |
574,517
-886,978
| -61% | -$110M |
|
310
Conagra Brands
CAG
$9.32B
| $71.1M | 0.04% |
2,479,853
-16,595
| -0.7% | -$476K |
|
311
American Homes 4 Rent
AMH
$12.9B
| $69.7M | 0.04% |
1,937,343
+1,848,337
| +2,077% | +$66.5M |
|
312
Baxter International
BAX
$12.4B
| $69.4M | 0.04% |
1,794,361
-96,523
| -5% | -$3.73M |
|
313
GATX Corp
GATX
$5.99B
| $69.2M | 0.04% |
575,689
+200,055
| +53% | +$24.1M |
|
314
Waste Management
WM
$88.2B
| $68.5M | 0.04% |
382,244
+114,308
| +43% | +$20.5M |
|
315
Parker-Hannifin
PH
$96.3B
| $68.3M | 0.04% |
148,286
-21,754
| -13% | -$10M |
|
316
Kirby Corp
KEX
$4.98B
| $67.9M | 0.04% |
865,001
+216,472
| +33% | +$17M |
|
317
NNN REIT
NNN
$8.12B
| $67.5M | 0.04% |
1,565,211
-451,348
| -22% | -$19.5M |
|
318
ATS Corp
ATS
$2.66B
| $67.1M | 0.04% |
1,548,566
+4,754
| +0.3% | +$206K |
|
319
Stride
LRN
$7.17B
| $66.7M | 0.04% |
1,124,141
-73,882
| -6% | -$4.39M |
|
320
AGCO
AGCO
$8.23B
| $66.6M | 0.04% |
548,314
-78,396
| -13% | -$9.52M |
|
321
Ameris Bancorp
ABCB
$5.08B
| $66.5M | 0.04% |
1,253,720
-51
| -0% | -$2.71K |
|
322
Brixmor Property Group
BRX
$8.5B
| $66.3M | 0.04% |
2,846,666
-557,178
| -16% | -$13M |
|
323
CDW
CDW
$22B
| $66M | 0.04% |
290,096
+36,031
| +14% | +$8.19M |
|
|
ENV
324
DELISTED
ENVESTNET, INC.
ENV
| $65.4M | 0.04% |
1,321,481
-143,753
| -10% | -$7.12M |
|
325
WNS Holdings
WNS
$3.24B
| $65M | 0.04% |
1,027,744
-37,919
| -4% | -$2.4M |
|